Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve research firms that are currently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $10.7778.
A number of brokerages have recently commented on AVAH. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a report on Wednesday, June 3rd. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Truist Financial lifted their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, Barclays raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th.
Get Our Latest Research Report on AVAH
Aveanna Healthcare Price Performance
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. The company’s revenue was up 15.9% compared to the same quarter last year. As a group, equities analysts predict that Aveanna Healthcare will post 0.68 earnings per share for the current year.
Insiders Place Their Bets
In other news, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the sale, the insider directly owned 10,112,123 shares in the company, valued at $80,998,105.23. The trade was a 19.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 3,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the completion of the sale, the insider directly owned 190,130 shares of the company’s stock, valued at approximately $1,522,941.30. This trade represents a 94.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 31,305,664 shares of company stock valued at $215,555,910 over the last quarter. Corporate insiders own 5.30% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of AVAH. Vanguard Group Inc. boosted its position in shares of Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Geode Capital Management LLC increased its stake in Aveanna Healthcare by 17.7% during the 4th quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after purchasing an additional 278,429 shares in the last quarter. Nuveen LLC lifted its stake in shares of Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after buying an additional 905,316 shares during the period. State Street Corp raised its stake in Aveanna Healthcare by 20.9% in the 4th quarter. State Street Corp now owns 1,483,265 shares of the company’s stock worth $12,118,000 after acquiring an additional 256,392 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Aveanna Healthcare by 49.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after purchasing an additional 441,707 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- These Outperforming Giants Are Boosting Dividends in 2026, With Yields of Up to 6.6%
- Why Analysts Are Bullish on a Stock That’s Down 20%
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
